Quris is an Israel-based artificial intelligence (AI)-driven company, founded in 2019. After two funding rounds, with the last seed round in 2022, they raised a total $28M from multiple investors.
Quris aims to reduce the drug development costs by predicting the safety profiles of the drugs, for which they developed a Bio-AI Clinical Prediction Platform. The company claims to have a disruptive approach: instead of using few organs on chip, they train their algorithm with the data from patient-on-chip.